Y-mAbs Therapeutics, Inc.·4

Dec 12, 8:26 AM ET

Wedell-Wedellsborg Johan 4

4 · Y-mAbs Therapeutics, Inc. · Filed Dec 12, 2023

Insider Transaction Report

Form 4
Period: 2023-12-11
Wedell-Wedellsborg Johan
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2023-12-11$6.85/sh+6,455$44,2324,559,233 total(indirect: By WG Biotech ApS)
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $6.85 to $6.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.

Documents

1 file
  • 4
    tm2332647-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT